Friday, August 08, 2008 Free Registration Log-in to View Profiles
Empire Relations Group is a Premier Investor Relations Organization representing publicly-traded companies in their communications programs with existing shareholders and potential investors.
investments
OTCBB
OTCBB
Pressroom 
 
 Archived
 
 Non-Public Companies
 Consumer
 Energy, Environment & Natural Resources
 Financials
 Healthcare/BioTech
 Industrials
 IT & Computers
 Materials
 Telecommunications
 Utilities
 
 Public Companies
 Consumer
 Energy, Environment & Natural Resources
 Financials
 Healthcare/BioTech
 Industrials
 IT & Computers
 Materials
 Telecommunications
 Utilities
Search


Public Companies : Healthcare/BioTech


Protherics PLC announces Block Listing Return - 4

Apr 10, 2008 - 1:36:04 PM

News Source MARKET WIRE

Email this article
 Printer friendly page
Cheshire, UK -- (MARKET WIRE) -- 04/10/08 --

                                 Protherics PLC                         6 monthly Block Listing Return                         Unapproved Share Option SchemeLondon, UK; Brentwood, TN; 10 April 2008 - Protherics PLC ("Protherics" or the"Company"), the international biopharmaceutical company focused on critical careand cancer, in accordance with Listing Rule 3.5.6, notifies the followingdetails in respect of the block listing for its Unapproved Share Option Scheme:Name of applicant:                                         Protherics PLCName of scheme:                                            Protherics PLC Unapproved Share Option SchemePeriod of return:                           From:          9 October 2007         To:        8 April 2008Balance under scheme from previous return:                 3,126,947Plus: The amount by which the block scheme has been        Nilincreased, if the scheme has been increased since the dateof the last return:Less: Number of securities issued/allotted under scheme    Nilduring period:Equals: Balance under scheme not yet issued/allotted at    3,126,947end of periodNumber and class of securities originally listed and the   4,559,122 Ordinary Shares (date of admission: 8 April 2005)date of admissionName of contact:                                           Julie VickersTelephone number of contact:                               +44 (0) 1928 518010                                   |  Ends  |For further information please contact:ProthericsNick Staples, Director of Corporate Affairs                                     +44 (0) 7919  480510Julie Vickers, Company Secretary                                                +44 (0)1928 518010Financial Dynamics - press enquiriesLondon: Ben Atwell, Lara Mott                                                   +44 (0) 20 7831 3113New York: John Capodanno, Jonathan Birt                                         +1 212 850 5600Or visit  www.protherics.com                      This information is provided by RNS            The company news service from the London Stock Exchange



Top of Page | Main News Index | EmpireRelations.com Home Page EmpireRelations.com Selected Clients News

Come see our services. Copr. © 2005 Empire Relations Group, Inc.

Healthcare/BioTech
Latest Headlines
BioAlliance Pharma SA complements its portfolio with a European license for ondansetron RapidFilm(TM)
ViRexx Announces Approvals of Rights Offering
Amarillo Biosciences to Support Western Australian Government Sponsored Human Influenza Clinical Trial in Perth, Australia
ORLive Presents: Cryoballoon Procedure - Arctic Front
Sinobiopharma, Inc.: Name Change and Forward Stock Split
UCB reports financials in line with expectations, integration completed, R&D milestones achieved and stronger focus on core business
Electro-Optical Sciences Announces $11.8 Million Registered Direct Offering
Notice of Paladin Labs' Second Quarter Results Conference Call
Cytokinetics, Incorporated Reports Second Quarter 2008 Financial Results
China Health Care Corporation (CHCC) Announces Merger With United Premier Medical Group